The global Organoids market was valued at USD 1.1 Bn in 2024 and is projected to surpass USD 4.2 Bn by the end of 2035, expanding at a CAGR of 13.4% from 2025 to 2035. The growth is driven by increasing adoption of organoid models in drug discovery, personalized medicine, and disease modeling, along with rising investments in advanced biomedical research and regenerative medicine. Recent...